Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination medication used for the eradication of *Helicobacter pylori*. It typically contains a proton pump inhibitor (e.g., omeprazole or esomeprazole), amoxicillin, and clarithromycin.
## Primary Indications
* Treatment of duodenal ulcer disease associated with *Helicobacter pylori* infection.
* Treatment of gastric ulcer disease associated with *Helicobacter pylori* infection.
## Adult Dosing
The standard adult dose is one capsule or pack taken twice daily for 10 to 14 days. The exact composition of the capsule/pack (e.g., specific PPI, amoxicillin dose, clarithromycin dose) varies by product. Always refer to the specific product's prescribing information for exact components and strengths.
## Pediatric Dosing
Pediatric dosing is not well-established for this combination product. Treatment decisions in pediatric patients should be based on expert recommendations and individualized assessment.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment for amoxicillin is generally required unless severe. Clarithromycin requires dose adjustment in severe renal impairment (CrCl < 30 mL/min). Omeprazole/esomeprazole generally do not require dose adjustment in renal impairment.
* **Hepatic Impairment:** Omeprazole/esomeprazole may require dose reduction in severe hepatic impairment. Clarithromycin also requires dose adjustment in moderate to severe hepatic impairment, especially if combined with renal impairment.
## Contraindications
* Hypersensitivity to any component of the formulation (e.g., penicillins, macrolides, PPIs).
* History of allergic reactions to penicillins.
* History of cholestatic jaundice/hepatic dysfunction associated with prior macrolide use.
* Electrolyte abnormalities (hypokalemia, hypomagnesemia) should be corrected prior to initiating PPI therapy.
## Adverse Effects
Common adverse effects include diarrhea, nausea, vomiting, abdominal pain, headache, taste disturbances, and rash. Serious adverse effects can include severe allergic reactions, *Clostridioides difficile*-associated diarrhea, QT prolongation (with clarithromycin), and interstitial nephritis.
## Key Drug Interactions
* **Clarithromycin:** Potent CYP3A4 inhibitor; interacts with numerous drugs including statins, anticoagulants, certain antiarrhythmics, and calcium channel blockers. May increase serum concentrations and risk of toxicity.
* **Proton Pump Inhibitors (PPIs):** Can affect absorption of other drugs by altering gastric pH (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors, digoxin). May decrease the efficacy of clopidogrel.
* **Amoxicillin:** Can decrease the efficacy of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of allergic reactions.
* Assess for *Clostridioides difficile*-associated diarrhea.
* Monitor renal and hepatic function, especially in patients with pre-existing impairment.
* Evaluate for treatment efficacy (e.g., resolution of ulcer symptoms, confirmation of *H. pylori* eradication via testing).
## Clinical Pearls
* This combination therapy is typically administered for a defined short course (10-14 days).
* Ensure patients complete the full course of antibiotics, even if symptoms improve.
* Administer PPI component usually 30 minutes before a meal.
* Re-testing for *H. pylori* eradication is generally recommended 4-6 weeks after completion of therapy.
---
*This information is intended for healthcare professionals. Always verify current prescribing information and consult with a qualified healthcare provider for specific patient care decisions.*
